文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

英格兰与威尔士婴儿呼吸道合胞病毒干预项目的静态队列模型与动态传播模型比较

Comparison of a static cohort model and dynamic transmission model for respiratory syncytial virus intervention programs for infants in England and Wales.
PubMed 文献 · Vaccine · 2024-02-16

研究以已发表的英格兰与威尔士婴儿单克隆抗体免疫预防成本效果动态传播模型为参考,将美国婴儿静态队列模型适配至相同数据后比较预测。当干预参数对齐时,静态队列模型预测的避免住院比例(季节性32.3%、季节性加补种51.3%)显著高于动态传播模型(17.8%、28.6%)。将单克隆抗体初始效力设为62.1%(平均效力39.3%)时,静态队列模型预测的避免住院为季节性17.4%、季节性加补种27.7%,最接近动态传播模型结果。结论认为干预效力参数化是两种模型预测差异的可能主要驱动因素。

要点

  • 干预参数对齐后,静态队列模型预测的避免住院比例高于动态传播模型。
  • 将单克隆抗体初始效力设为62.1%(平均39.3%)时,静态队列模型结果最接近动态传播模型。
  • 单克隆抗体效力参数化可能是静态队列模型与动态传播模型预测差异的主要驱动因素。

核心结论

  • 呼吸道合胞病毒单克隆抗体干预效力的参数化是静态队列模型与动态传播模型预测差异的可能主要驱动因素。

研究设计与样本

  • 研究以已发表的评估英格兰与威尔士婴儿单克隆抗体免疫预防成本效果的动态传播模型为参考模型,将先前发表的美国婴儿静态队列模型利用动态传播模型使用的相同数据源适配至英格兰与威尔士。
  • 两模型均采用一项随机临床试验估计的单克隆抗体效力:针对所有 medically attended 呼吸道合胞病毒发作的平均效力为74.5%,针对呼吸道合胞病毒住院的平均效力为62.1%。
  • 为对齐模型假设,研究者修改静态队列模型以纳入效力衰减。
  • 模型比较输出包括避免住院和避免全科医生就诊,分别针对季节性免疫策略和季节性加补种免疫策略进行估计。

主要发现

  • 当静态队列模型干预参数与动态传播模型干预参数对齐时,静态队列模型预测的避免住院比例(季节性32.3%;季节性加补种51.3%)显著高于动态传播模型(季节性17.8%;季节性加补种28.6%)。
  • 当单克隆抗体干预初始效力为62.1%、导致平均效力为39.3%时,静态队列模型最接近地复现了动态传播模型结果,预测避免住院比例为季节性17.4%、季节性加补种27.7%。
  • 避免全科医生就诊的结果与避免住院结果相似。

关键数值与推荐

  • 单克隆抗体针对所有 medically attended 呼吸道合胞病毒发作的平均效力为74.5%,针对呼吸道合胞病毒住院的平均效力为62.1%(均来自随机临床试验)。
  • 动态传播模型估计的间接效应较小,约比直接效应小100倍。
  • 静态队列模型干预参数对齐动态传播模型参数时,避免住院:季节性32.3% vs 季节性加补种51.3%(静态队列模型);季节性17.8% vs 季节性加补种28.6%(动态传播模型)。
  • 单克隆抗体初始效力62.1%、平均效力39.3%时,静态队列模型预测避免住院:季节性17.4%、季节性加补种27.7%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A recent study comparing results of multiple cost-effectiveness analyses (CEAs) in a hypothetical population found that monoclonal antibody (mAb) immunoprophylaxis for respiratory syncytial virus (RSV) in infants averted fewer medically attended cases when estimated using dynamic transmission models (DTMs) versus static cohort models (SCMs). We aimed to investigate whether model calibration or parameterization could be the primary driver of inconsistencies between SCM and DTM predictions. METHODS: A recently published DTM evaluating the CEA of infant mAb immunoprophylaxis in England and Wales (EW) was selected as the reference model. We adapted our previously published SCM for US infants to EW by utilizing the same data sources used by the DTM. Both models parameterized mAb efficacy from a randomized clinical trial (RCT) that estimated an average efficacy of 74.5% against all medically attended RSV episodes and 62.1% against RSV hospitalizations. To align model assumptions, we modified the SCM to incorporate waning efficacy. Since the estimated indirect effects from the DTM were small (i.e., approximately 100-fold smaller in magnitude than direct effects), we hypothesized that alignment of model parameters should result in alignment of model predictions. Outputs for model comparison comprised averted hospitalizations and averted GP visits, estimated for seasonal (S) and seasonal-with-catchup (SC) immunization strategies. RESULTS: When we aligned the SCM intervention parameters to DTM intervention parameters, significantly more averted hospitalizations were predicted by the SCM (S: 32.3%; SC: 51.3%) than the DTM (S: 17.8%; SC: 28.6%). The SCM most closely replicated the DTM results when the initial efficacy of the mAb intervention was 62.1%, leading to an average efficacy of 39.3%. Under this parameterization the SCM predicted 17.4% (S) and 27.7% (SC) averted hospitalizations. Results were similar for averted GP visits. CONCLUSIONS: Parameterization of the RSV mAb intervention efficacy is a plausible primary driver of differences between SCM versus DTM model predictions.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lang JC, Kura K, Garba SM, et al. Comparison of a static cohort model and dynamic transmission model for respiratory syncytial virus intervention programs for infants in England and Wales. Vaccine. 2024. PMID: 38368224. doi:10.1016/j.vaccine.2024.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。